What is the role of azathioprine in the treatment of polymorphous light eruption (PMLE)?

Updated: Jan 22, 2020
  • Author: Saud A Alobaida, MBBS, FRCPC; Chief Editor: Dirk M Elston, MD  more...
  • Print
Answer

Azathioprine was reported to be effective in two cases of recalcitrant severe disease at 0.8-2.5 mg/kg/d for 3 months. [59] In one patient, the effect lasted up to 4 months after the discontinuation of therapy. However, the limited available data and azathioprine toxicity should necessitate extreme caution if choosing this form of treatment.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!